Avanos Medical, Inc. (NYSE:AVNS) Shares Acquired by CANADA LIFE ASSURANCE Co

CANADA LIFE ASSURANCE Co grew its stake in Avanos Medical, Inc. (NYSE:AVNS) by 22.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 75,341 shares of the company’s stock after purchasing an additional 13,634 shares during the quarter. CANADA LIFE ASSURANCE Co owned approximately 0.16% of Avanos Medical worth $1,198,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of the stock. Marshall Wace LLP acquired a new position in Avanos Medical during the fourth quarter worth about $1,031,000. Mariner LLC boosted its position in Avanos Medical by 18.0% during the fourth quarter. Mariner LLC now owns 10,655 shares of the company’s stock worth $170,000 after acquiring an additional 1,625 shares during the last quarter. LSV Asset Management boosted its position in Avanos Medical by 68.5% during the fourth quarter. LSV Asset Management now owns 43,300 shares of the company’s stock worth $689,000 after acquiring an additional 17,600 shares during the last quarter. Martingale Asset Management L P boosted its position in Avanos Medical by 5.9% during the fourth quarter. Martingale Asset Management L P now owns 104,697 shares of the company’s stock worth $1,667,000 after acquiring an additional 5,868 shares during the last quarter. Finally, Invesco Ltd. boosted its position in Avanos Medical by 28.8% during the fourth quarter. Invesco Ltd. now owns 363,738 shares of the company’s stock worth $5,791,000 after acquiring an additional 81,275 shares during the last quarter. Institutional investors and hedge funds own 95.17% of the company’s stock.

Insider Buying and Selling

In other news, SVP Kerr Holbrook sold 7,000 shares of the firm’s stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $15.25, for a total transaction of $106,750.00. Following the completion of the transaction, the senior vice president now directly owns 82,047 shares in the company, valued at $1,251,216.75. This trade represents a 7.86 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 2.64% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Separately, StockNews.com raised shares of Avanos Medical from a “hold” rating to a “buy” rating in a research note on Wednesday, March 19th.

Avanos Medical Trading Up 2.7 %

Shares of Avanos Medical stock opened at $12.68 on Tuesday. The firm has a market capitalization of $583.32 million, a price-to-earnings ratio of 37.29 and a beta of 1.15. Avanos Medical, Inc. has a fifty-two week low of $11.84 and a fifty-two week high of $25.36. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.46 and a current ratio of 2.22. The stock has a 50 day moving average of $13.94 and a 200 day moving average of $16.63.

Avanos Medical (NYSE:AVNS) last issued its quarterly earnings data on Wednesday, February 26th. The company reported $0.43 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.03. The company had revenue of $179.60 million during the quarter, compared to analyst estimates of $177.23 million. Avanos Medical had a return on equity of 4.70% and a net margin of 2.30%. As a group, research analysts predict that Avanos Medical, Inc. will post 1.32 earnings per share for the current year.

Avanos Medical Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.